Abstracts
Showing 800 abstracts.
Changes in Tenofovir Population Pharmacokinetics during Pregnancy
Study
P1026S
Clonal expansion, artificial censoring, and inverse probability weighting to compare the effects of multiple treatment management strategies after HAART failure among perinatally HIV-infected children and adolescents.
Influence of Age and Serum Creatinine on Population Pharmacokinetics of Emtricitabine in HIV-1 Infected Children
Study
P1021
Safety and Efficacy of Dolutegravir (DTG; GSK1349572) in Treatment-Experienced HIV-1 Infected Adolescents: 24-Week Results from IMPAACT P1093
Study
P1093
HIV-1 gp120 vaccination elicits a robust and durable anti-V1V2 IgG response and yet no HIV Env-specific IgA response in HIV-exposed infants
Dose-finding Pharmacokinetics (PK) and 24- and 48-Week Safety and Efficacy of Raltegravir (RAL) Granules for Suspension (GFS) Formulation in Human Immunodeficiency Virus type-1 (HIV)-Infected Infants Starting Treatment at 4 Wk – 6 Mo of Age
Study
P1066
Pharmacokinetics of Darunavir Once or Twice Daily During Pregnancy and Postpartum
Study
P1026S
Use of Dried Blood Spot Samples and In-house Assays for Assessment of Drug Resistance in HIV-Infected Children in Resource-Limited Settings
Study
P1060